About the Product

Description


Troxipot 300 Tablet contains Troxipide 300mg, a gastroprotective agent used for management of gastritis, peptic ulcers, and acid-related gastrointestinal disorders. It helps protect the gastric mucosa and supports healing of ulcerated tissue.

Troxipide works by enhancing gastric mucosal defense mechanisms, reducing oxidative stress, and promoting mucosal repair. This mechanism ensures effective protection against gastric acid damage and inflammation.

This tablet is commonly prescribed for chronic gastritis, duodenal ulcers, and NSAID-induced gastric lesions. Its oral tablet form provides convenient dosing, improved patient compliance, and sustained therapeutic effect.

For PCD pharma franchise partners, Troxipot 300 Tablet is a high-demand gastro care product, available at the best price for PCD pharma franchise. Its clinical effectiveness, prescriber trust, and growing prevalence of gastrointestinal disorders make it an essential addition to any gastroprotective medicine portfolio.

Common side effects may include mild nausea, headache, or gastrointestinal discomfort. Rarely, patients may experience allergic reactions such as rash, itching, or swelling. If severe symptoms occur, medical advice should be sought immediately.

Troxipot 300 Tablet is indicated for the treatment of gastritis, gastric and duodenal ulcers, dyspepsia, and other conditions associated with excessive gastric acid secretion or mucosal irritation, as prescribed by a healthcare professional.

Troxipot 300 Tablet should be taken exactly as prescribed, preferably after meals. Patients should avoid alcohol and foods that may irritate the stomach. Inform your doctor if you have liver or kidney issues or if symptoms persist despite treatment.

Store Troxipot 300 Tablet in a cool, dry place away from direct sunlight and moisture. Keep the tablets in their original packaging and out of reach of children. Do not use after the expiry date mentioned on the pack.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Troxipide 300mg Tablet in the PCD pharma franchise market?

Troxipide 300mg Tablet has strong demand in the gastroenterology, digestive health, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on gastrointestinal healthcare portfolios.

Why should medical distributors include Troxipide 300mg Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for gastric mucosal protection and gastrointestinal disorder management under medical supervision. Troxipide 300mg is a gastroprotective agent that helps protect and repair the gastric mucosal lining Commonly prescribed for gastritis, gastric ulcers, gastric mucosal lesions, and other acid-related gastrointestinal disorders as advised by healthcare professionals Helps promote healing of damaged stomach lining and supports mucosal defense mechanisms Frequently used as part of comprehensive treatment plans for digestive health conditions Convenient oral tablet formulation improves patient compliance and ease of administration Widely prescribed by gastroenterologists, physicians, and general practitioners This strengthens a comprehensive gastroenterology and digestive care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Troxipide 300mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong prescription demand in gastroenterology practice, repeat prescriptions, reliable supply chain support, and attractive margins in the gastrointestinal care segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.